FOLD - Amicus Therapeutics sees FY 2019 Galafold revenue as high as $181M January, 09 2020 07:51 AM Amicus Therapeutics Inc. Amicus Therapeutics (NASDAQ:FOLD) announces preliminary 2019 revenue and Galafold (migalastat) commercial updates.More news on: Amicus Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...